RSS-Feed abonnieren
Bitte kopieren Sie die angezeigte URL und fügen sie dann in Ihren RSS-Reader ein.
https://www.thieme-connect.de/rss/thieme/de/10.1055-s-00000011.xml
Dtsch Med Wochenschr 2005; 130(14): 880-882
DOI: 10.1055/s-2005-865102
DOI: 10.1055/s-2005-865102
Prinzip & Perspektive
Gastroenterologie/Onkologie© Georg Thieme Verlag Stuttgart · New York
Kolonkarzinom: Molekulare Marker
Colon cancer: molecular markersWeitere Informationen
Publikationsverlauf
eingereicht: 11.10.2004
akzeptiert: 18.2.2005
Publikationsdatum:
31. März 2005 (online)

Glossar
CRC = kolorektales Karzinom
CIN = chromosomale Instabilität
MSI = Mikrosatelliteninstabilität
Literatur
- 1
Ahlquist D A, Skoletsky J E, Boynton K A. et al .
Colorectal cancer screening by detection of altered human DNA in stool: feasibility
of a multitarget assay panel.
Gastroenterology.
2000;
119
1219-1227
MissingFormLabel
- 2
Arnold C N, Blum H E.
Molekulare Pathogenese des Kolonkarzinoms: Klinische Relevanz.
Dtsch Med Wochenschr.
2005;
130
809-811
MissingFormLabel
- 3
Arnold C N, Goel A, Boland C R.
Role of hMLH1 promoter hypermethylation in drug resistance to 5-fluorouracil in colorectal
cancer cell lines.
Int J Cancer.
2003;
106
66-73
MissingFormLabel
- 4
Barratt P L, Seymour M T, Stenning S P. et al .
DNA markers predicting benefit from adjuvant fluorouracil in patients with colon cancer:
a molecular study.
Lancet.
2002;
360
1381-1391
MissingFormLabel
- 5
Calistri D, Rengucci C, Bocchini R, Saragoni L, Zloi W, Amadori D.
Fecal multiple molecular tests to detect colorectal cancer in stool.
Clin Gastro Hepatol.
2003;
1
377-383
MissingFormLabel
- 6
Carethers J M, Smith E J, Behing C A. et al .
Use of 5-fluorouracil and survival in patients with microsatellite unstable colorectal
cancer.
Gastroenterology.
2004;
126
394-401
MissingFormLabel
- 7
Dong S M, Traverso G, Johnson C. et al .
Detecting colorectal cancer in stool with the use of multiple genetic targets.
J Natl Cancer Inst.
2001;
93
858-865
MissingFormLabel
- 8
Fallik D, Borrini F, Boige V. et al .
Microsatellite instability is a predictive factor of the tumor response to irinotecan
in patients with advanced colorectal cancer.
Cancer Res.
2003;
63
5738-5744
MissingFormLabel
- 9
Müller H M, Oberwalder M, Fiegl H. et al .
Methylaion changes in faecal DNA: a marker for colorectal screenng?.
Lancet.
2004;
363
1283-1285
MissingFormLabel
- 10
Ribic C M, Sargent D J, Moore M J. et al .
Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based
adjuvant chemotherapy for colon cancer.
N Engl J Med.
2003;
349
247-257
MissingFormLabel
- 11
Sidransky D, Tokino T, Hamilton S R. et al .
Identification of ras oncogene mutations in the stool of patients with curable colorectal
tumors.
Science.
1992;
256
102-105
MissingFormLabel
- 12
Traverso G, Shuber A, Levin B. et al .
Detection of APC mutations in fecal DNA from patients with colorectal tumors.
N Engl J Med.
2002;
346
311-320
MissingFormLabel
- 13
Traverso G, Shuber A, Olsson L. et al .
Detection of proximal colorectal cancers through analysis of faecal DNA.
Lancet.
2002;
359
403-404
MissingFormLabel
- 14
Watanabe T, Wu T T, Catalano P J. et al .
Molecular predictors of survival after adjuvant chemotherapy for colon cancer.
N Engl J Med.
2001;
344
1196-1206
MissingFormLabel
- 15
Zhou W, Goodman S N, Galizia G. et al .
Counting alleles to predict recurrence of early-stage colorectal cancers.
Lancet.
2002;
359
219-225
MissingFormLabel
Dr. med. Christian N. Arnold
Medizinische Universitätsklinik Freiburg, Abteilung Innere Medizin II
Hugstetter Straße 55
79106 Freiburg
Telefon: 0761/2703401
Fax: 0761/2703655
eMail: arnold@med1.ukl.uni-freiburg.de